Serum estradiol, CTX, PINP, OPG, RANKL concentration and BMD prior to aromatase inhibitors treatments in the AI-related MS-AEs group and control group are presented in S1 Table. The gene discussed is TNFSF11; the disease is myeloid sarcoma.